Frazier Life Sciences Management, L.P. Verona Pharma PLC Transaction History
Frazier Life Sciences Management, L.P.
- $1.7 Billion
- Q2 2024
A detailed history of Frazier Life Sciences Management, L.P. transactions in Verona Pharma PLC stock. As of the latest transaction made, Frazier Life Sciences Management, L.P. holds 3,314,349 shares of VRNA stock, worth $110 Million. This represents 2.82% of its overall portfolio holdings.
Number of Shares
3,314,349
Previous 3,014,349
9.95%
Holding current value
$110 Million
Previous $48.5 Million
1.19%
% of portfolio
2.82%
Previous 2.55%
Shares
5 transactions
Others Institutions Holding VRNA
# of Institutions
145Shares Held
66.8MCall Options Held
495KPut Options Held
486K-
Ra Capital Management, L.P. Boston, MA7.63MShares$253 Million1.66% of portfolio
-
Nea Management Company, LLC Timonium, MD5.58MShares$185 Million7.62% of portfolio
-
Deep Track Capital, LP Greenwich, CT4MShares$132 Million1.9% of portfolio
-
Vivo Capital, LLC Palo Alto, CA3.55MShares$118 Million7.58% of portfolio
-
Lee Ainslie Maverick Capital LTD | Dallas, Tx3.09MShares$102 Million0.88% of portfolio
About Verona Pharma plc
- Ticker VRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 60,954,200
- Market Cap $2.02B
- Description
- Verona Pharma plc, a clinical stage biopharmaceutical company, focuses on development and commercialization of therapies for the treatment of respiratory diseases with unmet medical needs. The company's product candidate is ensifentrine, an inhaled and dual inhibitor of the phosphodiesterase (PDE) 3 and PDE4 enzymes that acts as both a bronchodi...